A QALY is [still] a QALY is [still] a QALY?
Abstract Despite clinical evidence of drug superiority, therapeutic modalities, like combination immunotherapy, are mostly considered cost-ineffective due to their high costs per life year(s) gained. This paper, taking an ethical stand, reevaluates the standard cost-effectiveness analysis with that...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2024-03-01
|
| Colecção: | BMC Medical Ethics |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s12910-024-01036-w |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|